Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolution of cancer genes as a mutation-driven process.

H M Temin1

  • 1McArdle Laboratory, University of Wisconsin, Madison 53706.

Cancer Research
|April 1, 1988
PubMed
Summary

Cancer evolution may be driven by mutations, not just natural selection. Analyzing retrovirus intermediates suggests a mutation-driven process, offering insights into cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of biological effects of addition of DNA molecules to cells.

Developments in biological standardization·1998
Same author

In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.

Journal of virology·1997
Same author

The recombination rate is not increased when retroviral RNA is missing an encapsidation sequence.

Journal of virology·1996
Same author

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Journal of virology·1995
Same author

Genetics of retroviruses.

Annals of the New York Academy of Sciences·1995
Same author

The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene.

Journal of virology·1995

Area of Science:

  • Oncology
  • Virology
  • Evolutionary Biology

Background:

  • Cancer arises from accumulated somatic mutations within cell lineages.
  • Highly oncogenic retroviruses serve as a model for cancer cell evolution.
  • Understanding evolutionary drivers is key to cancer research.

Purpose of the Study:

  • To analyze intermediates in highly oncogenic retrovirus evolution.
  • To differentiate between selection-driven and mutation-driven models of retrovirus evolution.
  • To explore the role of mutations in oncogenesis.

Main Methods:

  • Comparative analysis of replication-competent retroviruses and protooncogene progenitors.
  • Examination of non-transforming intermediates in retrovirus evolution.
  • Assessment of retrovirus mutation rates during replication.

Main Results:

  • Intermediates in highly oncogenic retrovirus evolution are often non-transforming.
  • This suggests that evolution is not purely driven by selection.
  • High retrovirus mutation rates support a mutation-driven evolutionary model.

Conclusions:

  • Retrovirus evolution towards high oncogenicity appears to be mutation-driven.
  • Oncogenesis generally is at least partially mutation-driven.
  • Distinct mutational mechanisms may operate in different oncogenic processes.

Related Experiment Videos